Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon and retinal vasculitis].

C Fardeau1

  • 1Service d'Ophtalmologie, Hôpital de la Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13. christine.fardeau@psl.ap-hop-paris.fr

Journal Francais D'Ophtalmologie
|August 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Phuc LeHoang: A giant in ophthalmology].

Journal francais d'ophtalmologie·2025
Same author

[Manifestations of ocular syphilis in a couple].

Journal francais d'ophtalmologie·2024
Same author

Choroidal hypoperfusion and diffuse retinal occlusive arteritis associated with varicella-zoster virus: A case report.

Journal francais d'ophtalmologie·2023
Same author

[Systemic lupus erythematosus and ischemic macular retinopathy: A case report].

Journal francais d'ophtalmologie·2022
Same author

[Snowy exudates in a branch retinal vein occlusion].

Journal francais d'ophtalmologie·2021
Same author

[Observational study of QuantiFERON® management for ocular tuberculosis diagnosis: Analysis of 244 consecutive tests].

La Revue de medecine interne·2020
Same journal

Silent threat to sight after bariatric surgery: Vision loss from vitamin A deficiency.

Journal francais d'ophtalmologie·2026
Same journal

Persistent subretinal fluid and subretinal precipitates following pneumatic retinopexy.

Journal francais d'ophtalmologie·2026
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
See all related articles

Systemic steroids are the first-line treatment for noninfectious posterior uveitis. Combining steroids with other drugs may reduce side effects and improve outcomes for retinal vasculitis.

Area of Science:

  • Ophthalmology
  • Immunology

Context:

  • Noninfectious posterior uveitis poses a risk of severe vision loss.
  • Systemic steroids are the primary treatment, but high doses can cause significant side effects.
  • Therapeutic combinations are considered when daily prednisone exceeds 0.3mg to mitigate steroid toxicity.

Purpose:

  • To explore alternative and adjunctive therapies for noninfectious posterior uveitis.
  • To evaluate the potential of immunomodulative and immunosuppressive drugs in managing intraocular inflammation.
  • To assess the role of interferons, particularly interferon alpha, in treating retinal vasculitis.

Summary:

  • Conventional treatment for noninfectious posterior uveitis involves systemic steroids.
  • When high-dose steroids are required, combining them with immunosuppressive or immunomodulative agents is a strategy to reduce steroid-related toxicity.

Related Experiment Videos

  • Emerging therapies include polyclonal/monoclonal antibodies and interferons, with interferon alpha showing promise in Behçet's disease.

    • Impact:

    • Highlights the limitations of high-dose steroid therapy in uveitis management.
    • Suggests the need for further research into combination therapies to improve patient outcomes and reduce side effects.
    • Emphasizes the importance of randomized studies to validate the efficacy of interferons in diverse retinal vasculitis etiologies.